AG-014699 phosphate

For research use only. Not for therapeutic Use.

  • CAT Number: I003606
  • CAS Number: 459868-92-9
  • Molecular Formula: C₁₉H₂₁FN₃O₅P
  • Molecular Weight: 421.36
  • Purity: ≥95%
Inquiry Now

AG-014699 phosphate(Cat No.:I003606), also known as Rucaparib phosphate, is a potent PARP (poly ADP-ribose polymerase) inhibitor. It works by inhibiting the PARP enzyme, which is involved in DNA repair, particularly single-strand break repair. By blocking PARP activity, AG-014699 induces synthetic lethality in cancer cells with deficient homologous recombination repair, such as BRCA1 or BRCA2 mutations, leading to cell death. This makes it a valuable therapeutic in cancer treatment, particularly for ovarian and breast cancers. Its phosphate form improves solubility and bioavailability for clinical applications in oncology.


Catalog Number I003606
CAS Number 459868-92-9
Synonyms

8-fluoro-2-(4-((methylamino)methyl)phenyl)-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one phosphate

Molecular Formula C₁₉H₂₁FN₃O₅P
Purity ≥95%
Target Epigenetics
Solubility DMSO: ≥ 33 mg/mL
Storage 3 years -20C powder
IC50 1.4 nM (Ki)
Reference

<p style=/line-height:25px/>
<br>[1]. Thomas HD, et al. Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial. Mol Cancer Ther, 2007, 6(3), 945-956.
<br>[2]. Hunter JE, et al. NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699. Oncogene, 2012, 31(2), 251-264.
<br>[3]. Daniel RA, et al. Central nervous system penetration and enhancement of temozolomide activity in childhood medulloblastoma models by poly(ADP-ribose) polymerase inhibitor AG-014699. Br J Cancer, 2010, 103(10), 1588-1596.
<br>[4]. Daniel RA, et al. Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. Clin Cancer Res, 2009, 15(4), 1241-1249.
</p>

Request a Quote